Matthias Theobald

4PUBLICATIONS
15CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
Treatment intensification does not improve outcomes beyond rituximab-based therapy in primary mediastinal B-cell lymphoma: a multicenter retrospective analysis.

|Sep 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

Sedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi

|Mar 16, 2023
A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination.

Matthias Birtel, Ralf-Holger Voss, Katharina Reinhard

|Apr 05, 2018
Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses.

Astrid Alflen, Nicole Stadler, Pamela Aranda Lopez

Pageof 1

Frequent Collaborators

1 joint publications

Markus P Radsak

1 joint publications

Benjamin Rengstl

1 joint publications

René Becker

1 joint publications

Martin Suchan